Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The study is for patients with advanced melanoma who are eligible for standard therapy with Pembrolizumab.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Przewidywana długość życia co najmniej 3 miesiące
- •Potwierdzony czerniak stadium 3 (nieoperacyjny) lub stadium 4 (przerzuty)
- •Co najmniej jedno zmieniające się ognisko nowotworu widoczne na badaniu CT lub MRI
- •Znana mutacja genu BRAF V600 lub zgoda na badanie tej mutacji
- •Radioterapia ukończona co najmniej 2 tygodnie przed rozpoczęciem badania
- •Dobra ogólna kondycja zdrowotna (przeprowadzenie standardowych badań krwi)
- •U kobiet w wieku rozrodczym: ujemny test ciążowy i stosowanie antykoncepcji przez 120 dni po ostatniej dawce
✗ Disqualifies
- •Czerniak pochodzenia ocznego (z oka)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 6, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (127)
Ironwood Cancer & Research Centers
Chandler, United States
Genesis Cancer and Blood Institute
Hot Springs, United States
Helios Clinical Research
Los Angeles, United States
Providence Medical Foundation
Santa Rosa, United States
UCHealth Memorial Hospital Central
Colorado Springs, United States
Christiana Care
Newark, United States
Bioresearch Partner
Hialeah, United States
Florida Clinical Trials Group - Tamarac
Tamarac, United States
The Center for Cancer and Blood Disorders
Bethesda, United States
MidAmerica Cancer Care
Kansas City, United States
Washington University School of Medicine in St. Louis
St Louis, United States
Gabrail Cancer Center Research LLC
Canton, United States
University of Pittsburgh Medical Center(UPMC)-Hillman Cancer Center
Pittsburgh, United States
Patientcare Clinical Research
Sugar Land, United States
Cancer Care Wollongong
Wollongong, Australia
Icon Cancer Centre Chermside
Chermside, Australia
Southern Adelaide Local Health Network Incorporated Flinders Medical Centre
Bedford Park, Australia
Eastern Health
Box Hill, Australia
Peninsula and South Eastern Haematology and Oncology Group
Frankston, Australia
Universitätsklinikum Graz
Graz, Austria
Universitair Ziekenhuis Antwerpen
Edegem, Belgium
Cliniques Universitaires Saint-Luc
Brussels, Belgium
Centre Hospitalier Universitaire Universite Catholique de Louvain - Site Godinne
Yvoir, Belgium
Universitair Ziekenhuis Leuven - Campus Gasthuisberg
Leuven, Belgium
Algemeen Ziekenhuis Groeninge - Campus Kennedylaan
Kortrijk, Belgium
Vitaz Primary Location
Sint-Niklaas, Belgium
Sunnybrook Research Ins<tute
Toronto, Canada
Masaryk Memorial Cancer Institute
Brno, Czechia
University Hospital Hradec Kralove
Sokolov, Czechia
Aarhus Universitetshospital
Aarhus, Denmark
Aalborg University Hospital
Aalborg, Denmark
Oulu University Hospital
Oulu, Finland
Tampere University Hospital
Tampere, Finland
Helsinki University Hospital
Helsinki, Finland
Centre Hospitalier Lyon-Sud
Pierre-Bénite, France
A Paré
Boulogne, France
Centre Hospitalier Universitaire Grenoble Alpes
La Tronche, France
CHU Lille
Lille, France
Hôpital La Timone
Marseille, France
Centre Hospitalier Universitaire (CHU) Nice
Nice, France
Hôpital Bichat AP-HP Université Paris Cité
Paris, France
ICO Saint Herblain
Saint-Herblain, France
CHU Rouen
Rouen, France
Hospital Saint Andre
Bordeaux, France
Universitätsmedizin Mannheim
Mannheim, Germany
Universitaetsklinikum Tuebingen (UKT)
Tübingen, Germany
Klinik für Dermatologie, Venerologie und Allergologie
Würzburg, Germany
University Hospital Erlangen
Erlangen, Germany
Universitätsklinik Hamburg Eppendorf
Martinsried, Germany
Universität Leipzig
Haus, Germany
Elbe Kliniken Stade-Buxtehude
Buxtehude, Germany
Johannes Wesling Klinikum Minden
Minden, Germany
University of Mainz Medical Center
Mainz, Germany
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Kiel, Germany
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Lübeck, Germany
Charite Department of Dermatology, Venereology and Allergology
Berlin, Germany
University Hospital Carl Gustav Carus Dresden
Dresden, Germany
Helios Klinikum Erfurt
Erfurt, Germany
SRH Wald-Klinikum Gera GmbH
Gera, Germany
Fachklinik Hornheide
Münster, Germany
National Institute of Oncology
Budapest, Hungary
University of Pécs
Pécs, Hungary
Soroka medical center
Beersheba, Israel
Rabin Medical Center
Petah Tikva, Israel
Ella Lemelbaum Institute for Immuno-Oncology and Melanoma
Ramat Gan, Israel
Tel Aviv Medical Center
Tel Aviv, Israel
Ospedale Casa Sollievo Della Sofferenza
San Giovanni Rotondo, Italy
Azienda Ospedaliera Universitaria SS Antonio e Biagio e Cesare Arrigo
Alessandria, Italy
Ospedale San Vincenzo Taormina
Messina, Italy
Fondazione IRCSS - Istituto Nazionale dei Tumori
Milan, Italy
AOU Policlinico di Modena
Modena, Italy
Istituto Oncologico Veneto IRCCS
Padova, Italy
Azienda Provinciale per I Servizi Sanitari
Trento, Italy
IRCCS Ospedale Policlinico San Marino
Genoa, Italy
IRCCS Ospedale San Raffaele
Milan, Italy
Humanitas Gavazzeni Bergamo
Bergamo, Italy
Clinica Oncologia Delle Marche
Ancona, Italy
UOC Immunoterapia Oncologica
Siena, Italy
Christchurch Public Hospital
Christchurch, New Zealand
Auckland City Hospital
Auckland, New Zealand
Nordland Hospital Trust
Bodø, Norway
Oslo University Hospital - The Norwegian Radium Hospital
Oslo, Norway
Drammen Hospital
Drammen, Norway
Uniwersyteckie Centrum Kliniczne
Gdansk, Poland
Prezychodnia Lekarska KOMED Roman Karaszewski
Konin, Poland
Mazowiecki Szpital Wojewódzki, Siedlckie Centrum Onkologii
Siedlce, Poland
Maria Sklodowska-Curie Na;onal Research Ins;tute of Oncology, Gliwice Branch
Gliwice, Poland
Maria Sklodowska-Curie National Cancer Research Institute
Warsaw, Poland
IPO Lisboa
Lisbon, Portugal
Hospital da Luz Lisboa
Lisbon, Portugal
Military Medical Academy- Department of Oncology
Belgrade, Serbia
Cancercare Port Elizabeth - Langenhoven Drive Oncology Centre
Port Elizabeth, South Africa
University of Pretoria, Steve Biko Academic Hospital
Pretoria, South Africa
The Medical Oncology Centre of Rosebank
Saxonwold, South Africa
Abraham Oncology
Richards Bay, South Africa
Curo Oncology
Pretoria, South Africa
Cape Town Oncology Trials
Cape Town, South Africa
TASK Eden
George, South Africa
Kyungpook National University Chilgok Hospital
Daegu, South Korea
Seoul National University Hospital
Seoul, South Korea
Hospital Clínico de Santiago de Compostela
Santiago de Compostela, Spain
H. Germans Trias I Pujol (ICO-Badalona)
Badalona, Spain
Hospital Universitari Dexeus
Barcelona, Spain
Vall d' Hebron Institute of Oncology
Barcelona, Spain
Hospital Universitario Marques de Valdecilla
Santander, Spain
San Pedro de Alcántara Hospital
Cáceres, Spain
Hospital Universitario Lucus Augusti
Lugo, Spain
Institut Català d'Oncologia Girona (ICO Girona)
Girona, Spain
GenesisCare Madrid - Hospital San Francisco de Asís
Madrid, Spain
Hospital General Universitario Gregorio Marañón
Madrid, Spain
HM CIOCC
Madrid, Spain
Hospital 12 de Octubre
Usera, Spain
Hospital Regional Universitario
Málaga, Spain
Hospital Clinico Universitario Virgen de la Arrixaca
Murcia, Spain
Hospital Universitario Virgen de la Victoria
Málaga, Spain
Hospital Clinic Barcelona
Barcelona, Spain
IVO - Fundacion Instituto Valenciano de Oncologia
Valencia, Spain
INCLIVA Instituto de Investigación Sanitaria
Valencia, Spain
University Hospital of Jerez
Cadiz, Spain
Gävle Sjukhus
Gävle, Sweden
Karolinska University Hospital
Stockholm, Sweden
Universitätsspital Zürich
Zurich, Switzerland
Kantonsspital Graubünden
Chur, Switzerland
Belfast City Hospital, Belfast Health and Social Care Trust
Belfast, United Kingdom
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom
Sarah Cannon Research Institute London
London, United Kingdom
University Hospital Southampton
Southampton, United Kingdom
Trial contact
Krishna Kaza, Director Clinical Study Management
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/7/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.